Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

9

Number of overlapping holdings

20.0%

% of CANC's 45 holdings also in BBH

36.0%

% of BBH's 27 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus BBH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in BBH
Overlap
REGENERON PHARMACEUTICALS 5.6% 7.9% 5.6%
ILLUMINA INC 3.5% 4.2% 3.5%
ARGENX SE ADR 2.9% 4.4% 2.9%
GILEAD SCIENCES INC 2.9% 8.0% 2.9%
EXACT SCIENCES CORP 3.1% 2.1% 2.1%

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to BBH
MERCK & CO. INC. 5.6%
DAIICHI SANKYO CO LTD 4.0%
ASTRAZENECA PLC 3.8%
NOVARTIS AG 3.7%
REVOLUTION MEDICINES, INC. 3.1%
CHUGAI PHARMACEUTICAL CO LTD 2.7%
CELLDEX THERAPEUTICS INC 2.6%
BLUEPRINT MEDICINES CORP. 2.6%
BRISTOL-MYERS SQUIBB CO 2.5%
EXELIXIS INC 2.4%
CANC Underweight Relative to BBH
AMGEN INC -15.3%
VERTEX PHARMACEUTICALS INC -9.7%
GILEAD SCIENCES INC -5.2%
IQVIA HOLDINGS INC -4.9%
BIOGEN IDEC INC -4.3%
ICON PLC -4.2%
MODERNA, INC. -3.6%
BIOMARIN PHARMACEUTICAL INC -3.1%
NEUROCRINE BIOSCIENCES INC -2.8%
CHARLES RIVER LABORATORIES -2.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY